U
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
Bermuda
Recent Filings
- SC 13D/A68.6 KBUrovant Sciences Ltd.Mar 30, 12:12 PM ET·0001193125-21-099584
- 8-K288.4 KBUrovant Sciences Ltd.Mar 29, 8:35 AM ET·0001193125-21-097522
- 8-K24.9 KBUrovant Sciences Ltd.Mar 24, 4:29 PM ET·0001193125-21-092665
- SC 13G/A64.3 KBUrovant Sciences Ltd.Feb 16, 3:38 PM ET·0001193125-21-044731
- 10-Q9.1 MBUrovant Sciences Ltd.Feb 12, 5:01 PM ET·0001564590-21-005814
- 8-K310.5 KBUrovant Sciences Ltd.Feb 12, 4:10 PM ET·0001564590-21-005780
- 8-K37.5 KBUrovant Sciences Ltd.Feb 11, 8:05 AM ET·0001193125-21-037406
- 8-K90.9 KBUrovant Sciences Ltd.Feb 9, 5:00 PM ET·0001564590-21-005040
- 8-K50.5 KBUrovant Sciences Ltd.Dec 23, 4:08 PM ET·0001193125-20-325982
- 8-K39.8 KBUrovant Sciences Ltd.Nov 24, 5:08 PM ET·0001193125-20-302694
Insiders
10- BANSAL AJAYPFO;CFO/Urovant Sciences, Inc.
- Dexcel Pharma Technologies Ltd.10% Owner
- Dexxon Holdings Ltd.10% Owner
- Ebersole NoriSVP&CHRO-Urovant Sciences,Inc.
- Haag-Molkenteller CorneliaCMO of Urovant Sciences, Inc.
- HALVORSEN OLE ANDREAS10% Owner
- Hindman James M.Director
- Johnston WaltSVP, Commercial, USI
- Katkin KeithDirector, PEO;CEO-Urovant Sciences,Inc.
- Kurstjens SefDirector
Tickers
No tickers on record
Addresses
business
5281 CALIFORNIA AVENUE SUITE 100
IRVINE, CA, 92617
mailing
5281 CALIFORNIA AVENUE SUITE 100
IRVINE, CA, 92617